Esophageal Cancer Market Poised to Hit $2.16 Billion by 2029 with Accelerating Growth Trends

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

Esophageal Cancer Market Size Growth Forecast: What to Expect by 2025?
Over the past few years, the esophageal cancer market has seen substantial growth. It is expected to escalate from $1.39 billion in 2024 to $1.52 billion in 2025, with a compound annual growth rate (CAGR) of 9.3%. Factors contributing to this growth during the historic period include a higher incidence of cancers, improvements in healthcare infrastructure, an increase in alcohol consumption, a surge in demand for preventive healthcare solutions, and a rise in esophageal adenocarcinoma prevalence.

How Will the Esophageal Cancer Market Size Evolve and Grow by 2029?
Anticipated robust expansion is on the horizon for the esophageal cancer market in the coming years. By 2029, it is projected to swell to a size of $2.16 billion, with a compound annual growth rate (CAGR) of 9.3%. Several factors are believed to be contributing to this expected growth during the forecast period. These include the escalating number of esophageal cancer cases, a heightened public awareness of health care, improvements in the health care infrastructure, habits such as chronic smoking and alcohol consumption, and the rise in cases of esophageal adenocarcinoma. Noteworthy trends anticipated throughout this period encompass advancements in technological treatment solutions, an increase in R&D investments, the growing use of precision medicine, the advent of targeted therapies, a heightened engagement in clinical trials and strengthened collaborations among academicians, pharmaceutical firms, and health care institutions.

View the full report here:
https://www.thebusinessresearchcompany.com/report/esophageal-cancer-global-market-report

What Drivers Are Propelling the Growth of Esophageal Cancer Market Forward?
The expansion of the esophageal cancer market is anticipated due to an escalation in esophageal cancer cases. This type of cancer impacts the esophagus, which is the tubular structure that links the throat to the stomach. As the occurrence of esophageal cancer amplifies, there is an increased necessity for diagnostic procedures, such as biopsies, endoscopy, and imaging tests, to identify and verify the disease. To illustrate, the American Cancer Society, a professional US organization, reports that in 2023, there were 16,120 newly recorded deaths caused by esophageal cancer and this figure is projected to climb to 16,130 in 2024. Therefore, the escalation in esophageal cancer cases is predicted to stimulate the growth of the esophageal cancer market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12637&type=smp

Which Emerging Trends Are Transforming the Esophageal Cancer Market in 2025?
Obtaining approval for new drugs is an emerging trend in the esophageal cancer market, and a strategy that major firms in the segmented are leveraging for competitive gain. One such example is Bristol Myers Squibb, a US pharmaceutical company, which in May 2022 received approval from the U.S. Food and Drug Administration (FDA) for two of its products, Opdivo (nivolumab) for intravenous use and Opdivo in combination with Yervoy (ipilimumab). These drugs, meant for patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC), were approved after a Phase 3 clinical trial showed improved survival rates in patients using these treatments.

What Are the Key Segments in the Esophageal Cancer Market?
The esophageal cancer market covered in this report is segmented -

1) By Type: Esophageal Squamous-Cell Carcinoma, Esophageal Adenocarcinoma, Other Types
2) By Treatment Type: Chemotherapy, Targeted Therapy, Other Treatment Types
3) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End Users: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:
1) By Esophageal Squamous-Cell Carcinoma: Localized Squamous-Cell Carcinoma, Advanced Squamous-Cell Carcinoma
2) By Esophageal Adenocarcinoma: Localized Adenocarcinoma, Advanced Adenocarcinoma
3) By Other Types: Neuroendocrine Tumors, Sarcomas, Mixed Cell Type Carcinomas

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=12637&type=smp

Who Are the Key Players Shaping the Esophageal Cancer Market's Competitive Landscape?
Major companies operating in the esophageal cancer market include Pfizer Inc., F. Hoffmann-La Roche Ltd., Merck & Co. Inc, AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A, Bristol-Myers Squibb Company, AstraZeneca PLC, GlaxoSmithKline Plc., Takeda Pharmaceutical Company Limited, Eli Lilly and Co Ltd., Boehringer Ingelheim International GmbH, Gilead Sciences Inc., Amgen Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Company Limited, Servier Pharmaceuticals, Eisai Co. Ltd., Sun Pharmaceutical Industries Limited, Otsuka Pharmaceutical Co. Ltd., Ipsen SA, Dr. Reddy's Laboratories Ltd., Seagen Inc., Exelixis Inc., BeiGene Ltd., Clovis Oncology Inc., Aslan Pharmaceuticals Ltd.

What Geographic Markets Are Powering Growth in the Esophageal Cancer Market?
North America was the largest region in the esophageal cancer market in 2024. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the esophageal cancer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12637

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.